Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTEDQuarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
---|---|---|---|---|
Q1 2024 | 3 | $0.55 | $0.55 | $0.55 |
Q2 2024 | 6 | $0.62 | $0.62 | $0.62 |
Q3 2024 | 3 | $0.39 | $0.39 | $0.39 |
Q4 2024 | 9 | $0.83 | $0.87 | $0.85 |
Q1 2025 | 5 | $0.50 | $0.60 | $0.56 |
Q2 2025 | 4 | $0.59 | $0.62 | $0.60 |
Q3 2025 | 4 | $0.54 | $0.56 | $0.55 |
Q4 2025 | 4 | $0.76 | $0.80 | $0.78 |
Q1 2026 | 3 | $0.60 | $0.63 | $0.62 |
Q2 2026 | 3 | $0.65 | $0.68 | $0.67 |
Q3 2026 | 3 | $0.66 | $0.70 | $0.68 |
Q4 2026 | 3 | $0.85 | $0.89 | $0.87 |
Integra LifeSciences Holdings Corporation last posted its earnings results on Monday, November 4th, 2024. The company reported $0.41 earnings per share for the quarter, topping analysts' consensus estimates of $0.39 by $0.02. The company had revenue of 380.83 M for the quarter and had revenue of 1.54 B for the year. Integra LifeSciences Holdings Corporation has generated $1 earnings per share over the last year ($0.84 diluted earnings per share) and currently has a price-to-earnings ratio of -258.53. Integra LifeSciences Holdings Corporation has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, February 26th, 2025 based on prior year's report dates.
Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
---|---|---|---|---|---|---|
11/04/2024 | Q3 2024 | $0.39 | -$0.14 | -0.53 | $375.81 M | $380.83 M |
07/29/2024 | Q2 2024 | $0.62 | -$0.16 | -0.78 | $413.07 M | $418.18 M |
05/06/2024 | Q1 2024 | $0.55 | -$0.04 | -0.59 | $368.87 M | |
12/30/2023 | Q4 2023 | $0.25 | $397.04 M | |||
10/25/2023 | Q3 2023 | $0.78 | $0.24 | -0.54 | $387.22 M | $382.42 M |
07/27/2023 | Q2 2023 | $0.05 | $374.01 M | $381.27 M | ||
04/26/2023 | Q1 2023 | $0.74 | $0.30 | -0.44 | $380.85 M | |
02/22/2023 | Q4 2022 | $0.93 | $0.63 | -0.3 | $398.02 M | |
10/26/2022 | Q3 2022 | $0.72 | $0.60 | -0.12 | $378.33 M | $385.19 M |
07/27/2022 | Q2 2022 | $0.80 | $0.54 | -0.26 | $395.35 M | $397.82 M |
04/27/2022 | Q1 2022 | $0.68 | $0.39 | -0.29 | $376.64 M | |
02/24/2022 | Q4 2021 | $0.54 | $405.52 M | |||
11/02/2021 | Q3 2021 | $0.72 | $0.51 | -0.21 | $384.62 M | $386.86 M |
07/29/2021 | Q2 2021 | $0.41 | $376.11 M | $389.99 M | ||
04/29/2021 | Q1 2021 | $0.54 | $360.07 M | |||
02/23/2021 | Q4 2020 | $1.10 | $388.65 M | |||
10/29/2020 | Q3 2020 | $0.38 | $351.65 M | $370.23 M | ||
08/10/2020 | Q2 2020 | $0.08 | -$0.00 | -0.08 | $243.82 M | $258.67 M |
05/07/2020 | Q1 2020 | $0.60 | $0.11 | -0.49 | $354.32 M | |
02/20/2020 | Q4 2019 | $0.18 | $395.13 M |
Integra LifeSciences Holdings Corporation has not confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, February 26th, 2025 based off last year's report dates.
In the previous quarter, Integra LifeSciences Holdings Corporation (:IART) reported $0.41 earnings per share (EPS) to beat the analysts' consensus estimate of $0.39 by $0.02.
The conference call for Integra LifeSciences Holdings Corporation's latest earnings report can be listened to online.
The conference call transcript for Integra LifeSciences Holdings Corporation's latest earnings report can be read online.
Integra LifeSciences Holdings Corporation (:IART) has a recorded annual revenue of $1.54 B.
Integra LifeSciences Holdings Corporation (:IART) has a recorded net income of $1.54 B. Integra LifeSciences Holdings Corporation has generated $0.87 earnings per share over the last four quarters.
Integra LifeSciences Holdings Corporation (:IART) has a price-to-earnings ratio of -258.53 and price/earnings-to-growth ratio is 1.96.
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTED